Population-based study of the impact of surgical and adjuvant therapy at the same or a different institution on survival of patients with pancreatic adenocarcinoma.
N LatchanaL DavisN G CoburnA MaharY LiuA HammadD KagedanM ElmiM SiddiquiC C EarleJulie HalletPublished in: BJS open (2018)
After pancreatectomy for pancreatic adenocarcinoma at specialized hepatopancreatobiliary surgery centres, OS was not affected by the location of the centre delivering adjuvant chemotherapy. Receiving this treatment in a local centre reduced patients' travel burden.